Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer

NCT03126071 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Advanced Colorectal Cancer

Interventions

DRUG: Raltitrexed
DRUG: Irinotecan
DRUG: Oxaliplatin
DRUG: Bevacizumab

Sponsor

Jiangsu Cancer Institute & Hospital